Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Neoplasms”

4,495 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,495 results

Testing effectiveness (Phase 2)Ended earlyNCT03215030
What this trial is testing

Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Teva Branded Pharmaceutical Products R&D LLC 272
Testing effectiveness (Phase 2)Study completedNCT03412565
What this trial is testing

Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 265
Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Not applicableUnknownNCT05119205
What this trial is testing

Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit

Who this might be right for
Multiple Myeloma Survival Outcome
Assiut University 64
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Not applicableStudy completedNCT06810115
What this trial is testing

Respiatory Viral Infections in Patients with Multiple Myeloma

Who this might be right for
Multiple MielomaRespiratory Viral Infections
University Medical Centre Ljubljana 219
Not applicableLooking for participantsNCT06659276
What this trial is testing

Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 83
Not applicableNot Yet RecruitingNCT07225738
What this trial is testing

Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
City of Hope Medical Center 700
Testing effectiveness (Phase 2)WithdrawnNCT02115035
What this trial is testing

A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT00004889
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT03275285
What this trial is testing

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

Who this might be right for
Plasma Cell Myeloma
Sanofi 302
Not applicableStudy completedNCT03602755
What this trial is testing

The First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

Who this might be right for
Multiple Myeloma
Celgene 706
Not applicableStudy completedNCT03135925
What this trial is testing

Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation

Who this might be right for
Myeloma
Sheffield Teaching Hospitals NHS Foundation Trust 23
Not applicableUnknownNCT02666755
What this trial is testing

Novel Detection System for Lung Cancer Curative Effect Monitoring

Who this might be right for
Lung Neoplasms
Jian Zhang 160
Testing effectiveness (Phase 2)Ended earlyNCT01653418
What this trial is testing

Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Looking for participantsNCT06376526
What this trial is testing

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dickran Kazandjian, MD 28
Not applicableStudy completedNCT03471897
What this trial is testing

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Chalmers University of Technology 237
Not applicableUnknownNCT03556748
What this trial is testing

WB-EMS and Nutrition in Patients With Hematological Malignancies

Who this might be right for
Hematologic DiseasesCachexia; CancerLeukemia+3 more
University of Erlangen-Nürnberg Medical School 40
Testing effectiveness (Phase 2)Study completedNCT01690143
What this trial is testing

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 45
Early research (Phase 1)Active Not RecruitingNCT04555551
What this trial is testing

MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 17
Load More Results